Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1218-1226
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1218
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1218
Table 2 Key outcome measures in cachectic patients with advanced pancreatic cancer over 12 wk of enteral feeding
| Outcome (n = 16) | Change (SD) |
| Average weight (kg) | +1.29 (5.8) |
| Body mass index (kg/m2) | +0.6 (1.7) |
| % Body fat | -1.6 (5) |
| Bone mineral density (T-score) | -0.01 (0.02) |
| Body fat mass (g) | -602 (2794) |
| Lean body mass (g) | +1273.1 (4078) |
| Appendicular lean mass (kg/m2) | +0.45 (0.62) |
| C-reactive protein (mg/mL) | -9.77 (SE 11.6) |
| Patient-reported outcomes | |
| NIH PROMIS (mean difference in score) | |
| Pain interference | -7.5 (P = 0.05) |
| Fatigue | -7.1 (P = 0.06) |
| Depression | -10.4 (P = 0.006) |
| EORTC QLQ-C30 (mean difference in score) | |
| Global health | +13.3 (P = 0.05) |
- Citation: Hendifar A, Akinsola R, Muranaka H, Osipov A, Thomassian S, Moshayedi N, Yang J, Jacobs J, Devkota S, Bhowmick N, Gong J. Gut microbiome and pancreatic cancer cachexia: An evolving relationship. World J Gastrointest Oncol 2022; 14(7): 1218-1226
- URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1218.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i7.1218